AbbVie Tshuag: Lub 20-xyoo Humira Monopoly xaus; Yog li, Tom ntej no yog dab tsi?

AbbVie's (ABBV) ob-xyoo caum Humira monopoly tuaj txog rau hnub Tuesday tom qab Amgen (AMGN) tau pib nws cov biosimilar knockoff ntawm 55% luv nqi rau tus thawj. Tab sis AbbVie Tshuag nce qib. X Lub biosimil ...

Yuav AbbVie Tshuag. Pharma Giant tseem tsim nyog muaj txawm tias Humira ploj mus.

Qee lub sij hawm, ib qho kev txhawj xeeb loj heev uas nws tsis pom txhua yam zoo tshwm sim tib lub sijhawm. Qhov ntawd yog rooj plaub nrog cov khoom lag luam ntawm cov khoom lag luam loj heev AbbVie uas nws cov tshuaj blockbuster Humira ntsib pate ...

Credit Suisse Hais tias AbbVie's Humira Patent Cliff tuaj yeem muab lub zog los txhawb kev loj hlob

Credit Suisse tau pib qhov kev pab cuam ntawm AbbVie Inc (NYSE: ABBV) nrog qhov kev ntsuas ua tau zoo thiab tus nqi phiaj ntawm $ 170. AbbVie sawv ntawm ntug ntawm qhov muag zoo tshaj plaws Humira US poob ntawm kev cais tawm (LOE) ...

Ups & Downs: Top Pharmaceutical Stocks Post-COVID

Leej twg yuav yog Big Pharma tus yeej tom qab-COVID? Getty Images Muaj kev sib cav me ntsis tias COVID-19 kev kis thoob ntiaj teb tau hloov kho lub ntiaj teb. Thaum tsev neeg thiab tsoomfwv txuas ntxiv mus nrog Omicron v ...

AbbVie cov khoom lag luam nce ntawm cov nyiaj tau los hauv peb lub quarter thib plaub raws li nws tshaj tawm tias kev muag khoom zoo dua li kev cia siab ntawm Humira

Ib qho dhau los ntawm tsab ntawv ceeb toom no tau xa mus rau Humana hauv xov xwm, tsis yog Humira. Nws tau raug kho lawm. Shares ntawm AbbVie Inc. ABBV, +0.08% tau nce 1.4% hauv kev lag luam ua ntej hnub Wednesday tom qab lub comp ...